Format

Send to

Choose Destination
Orv Hetil. 2019 Mar;160(9):322-328. doi: 10.1556/650.2019.31289.

[The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases].

[Article in Hungarian; Abstract available in Hungarian from the publisher]

Author information

1
I. Belgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Korányi Sándor u. 2/a, 1083.
2
Egészségfejlesztési és Klinikai Módszertani Intézet, Egészségtudományi Klinikai Tanszék, Semmelweis Egyetem, Egészségtudományi Kar Budapest.
3
MUHC, Montreal General Hospital, McGill University Montreal, Kanada.

Abstract

in English, Hungarian

The diagnostics of gastrointestinal diseases have evolved significantly in the past few decades. Besides endoscopy and conventional imaging modalities, there is a growing interest for rapid point-of-care laboratory tests to help discriminate between diseases with similar clinical symptoms and/or help the follow-up of chronic conditions, predicting relapses. The fecal calprotectin testing is a routine diagnostic tool in many countries. It is also more and more accessible in Hungary as well. We aim to present a short review on the role and performance of fecal calprotectin test in the diagnosis and follow-up of gastrointestinal diseases, especially inflammatory bowel diseases, gastrointestinal infections, irritable bowel syndrome and pediatric conditions. By presenting the different cut-off values, sensitivity and specificity rates representative for each disease, we hope to further aid clinicians in decision-making regarding these conditions. Orv Hetil. 2019; 160(9): 322-328.

KEYWORDS:

Crohn-betegség; Crohn’s disease; betegkövetés; colitis ulcerosa; fecal calprotectin; follow-up; gastroenteritis; gastrointestinal infections; relapse; relapsus; székletkalprotektin; ulcerative colitis

PMID:
30798622
DOI:
10.1556/650.2019.31289

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center